Peptides in Neurogenesis Research: Current Studies
Peptide neurogenesis research studies how Semax, PE-22-28, and NAD+ affect BDNF expression and hippocampal neuron formation in preclinical lab models.
Peptide neurogenesis research studies how Semax, PE-22-28, and NAD+ affect BDNF expression and hippocampal neuron formation in preclinical lab models.
Blood-brain barrier peptide research maps how peptides enter the CNS. Studies on Semax and Selank show these cross via active transport in lab models.
CNS bioregulator research: Cortagen, Semax, Selank, and PE-22-28 studied in neural and brain cell models. Cell and animal model data only.
Review B12 research: methylcobalamin in SH-SY5Y nerve cells and rat DRG neurons, homocysteine ELISA, MMA assay, and cobalamin form comparison.
Explore Adamax research: vasopressin B4 analog cell studies, GABA-B and NMDA receptor assays, HPLC methods, and LTP data in rat hippocampal models.
Neuroprotective peptide research on Semax, Selank, and PE-22-28: BDNF, TrkB, GABA-A, and CREB biomarker data from neuronal cell models.
PE-22-28 as a BDNF mimetic peptide. Cell model data on TrkB receptor binding, CREB signaling, and neuroplasticity studies in published lab models.
Dermorphin research covers a natural opioid peptide from frog skin with high mu-opioid receptor strength, studied in binding assays and animal models.
Oxytocin research reviewed: neuropeptide structure, receptor signaling pathways, HPA axis findings, and behavioral study data from published literature.
Brain peptides comparison covering Semax, Selank, and PE-22-28 research findings, mechanisms, and key differences across published laboratory studies.